Literature DB >> 15218359

The role of MRI in invasive lobular carcinoma.

Carla Boetes1, Jeroen Veltman, Lya van Die, Peter Bult, Theo Wobbes, Jelle O Barentsz.   

Abstract

PURPOSE: To determine the value of MR imaging in the detection and measurement of tumor size in patients with invasive lobular carcinoma (ILC) compared to mammography and ultrasound.
MATERIALS AND METHODS: From 36 cases of ILC in 34 patients who were surgically treated, the pre-operative imaging measurements, being mammography, ultrasound and contrast enhanced MR, were retrospectively re-evaluated for tumor detection and size. Findings were compared with pathology. Two radiologists were used for evaluation of the mammograms, the other imaging modalities were only evaluated by one radiologist. The Pearsons correlation test was used to determine the correlation between histopathological and imaging measurements for each imaging modality.
RESULTS: For mammography, ultrasound and MRI the false negative scores were respectively 14%, 3% and 0%. The percentage for underestimated, correctly estimated and overestimated measurements on imaging were 56%, 33% and 11% for radiologist 1 and 50%, 33% and 17% for radiologist 2 on mammography. For ultrasound and MRI these percentages were respectively 53%, 47%, 0% and 14%, 75%, 11%. The correlation coefficients for mammography were respectively r = 0.34 (p < 0.05) and r = 0.27 (p > 0.05) for both radiologists, for Ultrasound r = 0.24 (p > 0.05) and for MRI r = 0.81 (p < 0.01).
CONCLUSION: Of the three imaging modalities contrast enhanced MR has the lowest false negative rate in detecting ILC and has the highest accuracy in measuring the size of the ILC. MR could play a key role in the pre-operative work-up for accurate tumor size determination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218359     DOI: 10.1023/B:BREA.0000032921.10481.dc

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  28 in total

Review 1.  Pearls and pitfalls in breast MRI.

Authors:  I Millet; E Pages; D Hoa; S Merigeaud; F Curros Doyon; X Prat; P Taourel
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

2.  Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer?

Authors:  M Rominger; D Berg; T Frauenfelder; A Ramaswamy; N Timmesfeld
Journal:  Eur Radiol       Date:  2015-08-14       Impact factor: 5.315

3.  Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison.

Authors:  S Gruber; L Minarikova; K Pinker; O Zaric; M Chmelik; B Strasser; P Baltzer; T Helbich; S Trattnig; W Bogner
Journal:  Eur Radiol       Date:  2015-08-27       Impact factor: 5.315

4.  Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinoma.

Authors:  Sung Hun Kim; Eun Suk Cha; Chang Suk Park; Bong Joo Kang; In Yong Whang; A Won Lee; Byung Joo Song; Jeongmi Park
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

5.  Unifocal Invasive Lobular Carcinoma: Tumor Size Concordance Between Preoperative Ultrasound Imaging and Postoperative Pathology.

Authors:  Gopal R Vijayaraghavan; Srinivasan Vedantham; Gabriela Santos-Nunez; Rebecca Hultman
Journal:  Clin Breast Cancer       Date:  2018-07-27       Impact factor: 3.225

6.  Imaging features and conspicuity of invasive lobular carcinomas on digital breast tomosynthesis.

Authors:  Foucauld Chamming's; Ellen Kao; Ann Aldis; Romuald Ferré; Atilla Omeroglu; Caroline Reinhold; Benoit Mesurolle
Journal:  Br J Radiol       Date:  2017-04-03       Impact factor: 3.039

7.  High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

Authors:  K Pinker-Domenig; W Bogner; S Gruber; H Bickel; S Duffy; M Schernthaner; P Dubsky; U Pluschnig; M Rudas; S Trattnig; T H Helbich
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

8.  Factors Affecting Concordance between Radiological and Histological Findings in Invasive Lobular Carcinoma - Experience from a National Cancer Centre.

Authors:  Duaa Abu-Sinn; Donal O'Driscoll; Maurice Murphy
Journal:  Breast Care (Basel)       Date:  2017-02-07       Impact factor: 2.860

9.  Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast.

Authors:  D J Hadjiminas; K E Zacharioudakis; M K Tasoulis; J C C Hu; S Lanitis; R Bright-Thomas; N G Dimopoulos; G Hornzee; D A Cunningham; S J Cleator; R Al Mufti
Journal:  Ann R Coll Surg Engl       Date:  2015-11       Impact factor: 1.891

Review 10.  Promoter methylation and the detection of breast cancer.

Authors:  Jennifer Brooks; Paul Cairns; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2009-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.